- Home
- CLPS vs ASBP Comparison
CLPS vs ASBP Comparison
Compare CLPS & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPS
- ASBP
- Stock Information
- Founded
- CLPS 2005
- ASBP 2021
- Country
- CLPS Hong Kong
- ASBP United States
- Employees
- CLPS N/A
- ASBP N/A
- Industry
- CLPS Computer Software: Prepackaged Software
- ASBP Biotechnology: Pharmaceutical Preparations
- Sector
- CLPS Technology
- ASBP Health Care
- Exchange
- CLPS Nasdaq
- ASBP Nasdaq
- Market Cap
- CLPS 27.2M
- ASBP 26.6M
- IPO Year
- CLPS 2018
- ASBP N/A
- Fundamental
- Price
- CLPS $1.04
- ASBP $0.54
- Analyst Decision
- CLPS
- ASBP
- Analyst Count
- CLPS 0
- ASBP 0
- Target Price
- CLPS N/A
- ASBP N/A
- AVG Volume (30 Days)
- CLPS 7.8K
- ASBP 28.2M
- Earning Date
- CLPS 10-17-2025
- ASBP 08-13-2025
- Dividend Yield
- CLPS 12.18%
- ASBP N/A
- EPS Growth
- CLPS N/A
- ASBP N/A
- EPS
- CLPS N/A
- ASBP N/A
- Revenue
- CLPS $153,816,045.00
- ASBP N/A
- Revenue This Year
- CLPS N/A
- ASBP N/A
- Revenue Next Year
- CLPS N/A
- ASBP N/A
- P/E Ratio
- CLPS N/A
- ASBP N/A
- Revenue Growth
- CLPS 5.81
- ASBP N/A
- 52 Week Low
- CLPS $0.80
- ASBP $0.22
- 52 Week High
- CLPS $1.70
- ASBP $15.80
- Technical
- Relative Strength Index (RSI)
- CLPS 59.53
- ASBP 58.09
- Support Level
- CLPS $0.96
- ASBP $0.52
- Resistance Level
- CLPS $1.07
- ASBP $0.59
- Average True Range (ATR)
- CLPS 0.03
- ASBP 0.09
- MACD
- CLPS 0.01
- ASBP 0.00
- Stochastic Oscillator
- CLPS 81.25
- ASBP 37.10
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.
About ASBP Aspire Biopharma Holdings Inc. Common Stock
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.